Skip to main content
Log in

Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

It is well recognised that haemodialysis and renal transplant patients are at increased risk of developing non-A, non-B hepatitis. Recently the genome of hepatitis C virus (HCV), the major causative agent for non-A, non-B hepatitis, has been isolated.

Anti-HCV seroprevalence was assessed in all haemodialysis patients (266) in Ireland who in March 1990 had been dialysed for at least 6 months. For comparative purposes, 272 patients who had functioning renal transplants for greater than 6 months were also studied. Potential risk factors such as age, number of blood transfusions and time on dialysis were evaluated.

The prevalence of HCV infection as evidenced by antibody detection was only 1.1% for transplant and 1.7% for haemodialysis patients. This compares to a reported incidence of between 10% and 50% found elsewhere. Two of the 5 anti-HCV positive haemodialysis patients and 2 of the 3 transplant patients had biochemical evidence of liver disease. From stored sera it was possible to ascertain when patients acquired HCV.

Whether the very low prevalence of anti-HCV in Irish patients is due to the low prevalence of the virus in the general population, the policy of non reimbursement of blood donors, genetic or other factors, remains to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nielson V., Clausen E., Ranek L. Liver impairment during chronic haemodialysis and after renal transplantation. Acta Med Scand. 1975;197:229–234.

    Google Scholar 

  2. Weir M.R., Kirkmann R.L., Strom T.B., Tilney N.L. et al. Liver disease in recipients in of long-functioning renal allografts. Kidney International. 1985;28:839–844.

    Article  PubMed  CAS  Google Scholar 

  3. Toussaint C, Dupont E., Vanherweghem J.L., Cappel R., et al. liver disease in patients undergoing haemodialysis and kidney transplantation. Nephrology Yearbook 1979.269–293.

  4. Huang C.C., Lai M.K., Fong M.I. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients. Transplantation. 1990;49:540–544.

    Article  PubMed  CAS  Google Scholar 

  5. Feinstone S., Kapikan A., Purcell R., Alter H. et al. Tranfusion- associated hepatitis not due to viral hepatitis type A or B. The New England Journal of Medicine. 1975;292:767–770.

    PubMed  CAS  Google Scholar 

  6. Galbraith R., Portmann B., Eddelstown A.L., Williams R. Chronic liver disease developing after an outbreak of HbsAgnegative hepatitis in haemodialysis unit. Lancet 1975;887–890.

  7. Rakela J., Redker A.G. Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology. 1979;77:1200–1200.

    PubMed  CAS  Google Scholar 

  8. Berman M., Alter H.J., Ishak G., Purcell R.H. The chronic sequelae of non-A, non-B hepatitis. Annals of Internal Medicine 1979;91:1–6.

    PubMed  CAS  Google Scholar 

  9. Koretz R., Stone O., Gitnick G. The long-term course of non-A, non-B post-transfusion hepatitis. Gastroenterology 1980;79:893–898.

    PubMed  CAS  Google Scholar 

  10. Knodell R., Conrad M., Ishak K. Development of chronic liver disease after acute non-A,non-B post transfusion hepatitis. Gastroenterology 1977;72:902–909.

    PubMed  CAS  Google Scholar 

  11. Choo Q.L., Kuo G. Weiner A. J. Overby L.R. et al. Isolation of a cDN A clone derived from a blood borne non-A, non-B viral hepatitis genome. Science.1989;244:359–361.

    Article  PubMed  CAS  Google Scholar 

  12. Kuo G., Alter C., Gitnick G.L. Redeker A-G. et al. Anassay for circulating antibodies to a major etiologic virus of human non- A, non-B hepatitis. Science 1989;244:362–364.

    Article  PubMed  CAS  Google Scholar 

  13. Van Der Poel C.L., Reesink H.W., Leliei P.N., Leentvaar- Kuypers A. et al. Anti-hepatitis C antibodies and non-A, non-B post transfusion hepatitis in the Netherlands. Lancet 1989;297–298.

  14. Esteban J.I., Esteban R., Viladomiu L., Lopez-Talavera J.C. et al. Hepatitis C virus antibodies among risk groups in Spain.

  15. Zuckerman A.J. The elusive hepatitis C virus. British Medical Journal 1989; 299:871–872.

    PubMed  CAS  Google Scholar 

  16. Will the real hepatitis C stand up. Lancet 1989;307–308.

  17. Tremolada F., Casarin C, Tagger A., Ribero M.L. et at. Antibody to hepatitis C virus in post-transfusion hepatitis. Annals of Internal Medicine.1991;114:277–281.

    PubMed  CAS  Google Scholar 

  18. Schlipkoter U., Roggendorf M., Ernst G., Rasshofer R. et al. Hepatitis C antibodies in haemodialysis patients. Lancet. 1990; 1409–1410.

  19. Antibodies against hepatitis C virus (ant-HCV) in haemodialysis patients: Association with hepatitis B serological markers. Nephrology Dialysis and Transplantation. 1991;6:466–475.

    Google Scholar 

  20. Gilli P., Moretti M., Soffritti S., Menini C. Anti- HCV positive patients in dialysis units? Lancet 1990;336:243.

    Article  Google Scholar 

  21. Mondelli M., Smedile V., Piazza V., Villa G. et al. Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. Nephrology Dialysis and Transplantation 1991;6:480–483.

    CAS  Google Scholar 

  22. Hoofangle J., Gerety R., Tabor E., Feinstone S. et al. Transmission of non-A, non-B hepatitis. Annals of Internal Medicine. 1987;87:14–20.

    Google Scholar 

  23. Walsh T.J. Hepatitis C-Screening of blood donations. Irish Medical Journal.1991;84:41–42.

    PubMed  CAS  Google Scholar 

  24. Rumi M.G., Colombo M., Gringeri A., Mannuccio P. et al. High prevalence of antibody to hepatitis C virus in multitransfussed haemophiliacs with normal transaminase levels. Annals of Internal Medicine. 1990; 112:379–380.

    PubMed  CAS  Google Scholar 

  25. Garson J.A., Tuke P.W., Markis M., Briggs M. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus containing factor Viii concentrates. Lancet 1990; 336:1022–25.

    Article  PubMed  CAS  Google Scholar 

  26. Farci P., Alter H.J., Wong D., Miller R.H. et al. A long-term study of hepatitis C virus replication in non-A, non-B Hepatitis. The New England Journal of Medicine. 1991;325:98–104.

    PubMed  CAS  Google Scholar 

  27. Fagan E.A. Testing for hepatitis C virus. British Medical Journal 1991;303:535–6.

    PubMed  CAS  Google Scholar 

  28. Van der Poel C.L. Cuypers H.T.M. Reesnink H.W. et al. Confirmation of hepatitis C virus infection by new four antigen-recombinant immunoblot assay. Lancet 1991;337:317–9.

    Article  PubMed  Google Scholar 

  29. Cantu P., Mangano S., Masini L. et al. Prevalence of antibodies against hepatitis C virus in adialysis unit. Nephron 1992;61:337–338.

    PubMed  CAS  Google Scholar 

  30. Mondelli M.U., Cristina G., Piazza V. Cerino A. et al. High prevalence of antibodies to hepatitis C virus in haemodialysis units using a second generation assay. Nephron 1992;61: 350–351.1

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conlon, P.J., Walshe, J.J., Smyth, E.G. et al. Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland. I.J.M.S. 162, 145–147 (1993). https://doi.org/10.1007/BF02942105

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02942105

Keywords

Navigation